Disease-Free SurvivalTreatment OutcomeMorbidityRandomized Controlled Trials as TopicPrognosisQuality of LifeNo Abstract available for this article.doi:10.1007/BF02580296R. CalliesB. MillerW. AlbertiL. HeilmannSpringer-VerlagJournal of Cancer Research and Clinical Oncology...
et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database. Gut 67, 1306–1316 (2018). Article PubMed Google Scholar Ten Broeke, S. W. et al. Cancer risks for PMS2-associated lynch syndrome...
et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database. Gut 67, 1306–1316 (2018). Article PubMed Google Scholar Ten Broeke, S. W. et al. Cancer risks for PMS2-associated lynch syndrome...
Their prognosis is generally favorable, with 5-year survival rates of more than 97% and more than 80% in stages I and II, respectively [36]. Type II, or non-endometrioid type, accounts for 10% to 20% of endometrial cancers. They commonly are of serous and clear-cell histology and are...
It's really one of two cancers where there are worsening survival rates. And the rates are worsening greater for Black women compared with non-Black women. Many reasons have been suggested for this survival disparity, including higher incidence of more aggressive cancer biology such as endometrial...
National Cancer Data Base report of associations, patterns, and survival benefit of lymphadenectomy in endometrial cancer There are no randomized trials comparing outcomes of stereotactic radiosurgery (SRS) versus neurosurgical resection in the management of limited brain metastases. We sought to evaluate ...
and an estimated 8,000 women will die from the disease. For a majority of patients diagnosed with aggressive, high-grade tumors that have spread, the five-year survival rate is about 16 percent, though chemotherapy has been associated with improved survival, and new targeted agents are being ...
The 5-year survival rates for EC vary according to the stage at diagnosis. In patients with tumors localized to the uterus, the 5-year survival rate is ≥95%, but it decreases when the disease has spread beyond the uterus, with rates of 69% in patients with regional metastasis and rates...
Fortunately, the survival and cure rates for endometrial cancer are relatively high (Duong 2011; A.D.A.M. 2012). This is because abnormal vaginal bleeding is often among the first signs of endometrial cancer, prompting women to visit their gynecologist and typically receive an early diagnosis an...
conferring a good prognosis. However, 16% of EC patients have a metastatic disease with 5-year survival rate of 16.8%, which contributes disproportionally to disease mortality [5]. For those patients with uterine confined lesions and high-intermediate risk for recurrence, adjuvant radiotherapy (RT)...